期刊文献+

P450cam突变体蛋白表达、纯化与结晶的改进及其四突变体(F87L/Y96F/L244A/V247A)晶体结构

The Improved Procedure for The Expression, Purification and Crystallization of Mutants of Cytochrome P450cam and The Crystal Structure of The F87L/Y96F/L244A/V247A Mutant
下载PDF
导出
摘要 在P4 5 0cam突变体蛋白纯化过程中使用 2 80nm/ 392nm双波长比值检测蛋白质纯度 ,采用 β 巯基乙醇对蛋白质进行还原性保护 ,有效地缩短了纯化进程 ,纯化效率相应提高 .以PEG 80 0 0为沉淀剂经悬滴汽相扩散法筛选得到适合衍射的P4 5 0cam四突变体 (F87L/Y96F/L2 4 4A/V2 4 7A)晶体 ,在Mar Research面探测器系统上收集了0 2 2nm分辨率的X射线衍射数据 .采用同晶差值傅立叶法解析结构 ,最后的晶体学R因子和Rfree分别为 0 197和 0 2 4 7,键长偏差为 0 0 0 177nm ,键角偏差为 1 96°.结构测定显示P4 5 0cam四突变体 (F87L/Y96F/L2 4 4A/V2 4 7A)和P4 5 0cam野生型的整体构象无重大变化 ,突变后活性口袋变大而疏水性增加 ,这与突变设计预期目标一致 . The UV absorbance ratio (A(392)/A(280)) was developed to survey the purity of the P450cam mutant protein during the purification of the mutants protein. Thus the course of the purification became compact and the efficiency of the purification had been improved. beta-Mereaptoethenol had been developed to maintain the deoxidization of the protein during the purification. Crystals of the F87UY96F/1244A/V247A mutant were grown by vapor diffusion method. X-ray diffraction data were collected to 0.22 nm resolution on a Mar Research area detector in house. The structure was determined by Difference Fourier Method. The final crystallographic R factor and R-free factor are 0.197 and 0.247 respectively. The RMS deviations of bond length and angle of the mutants are 0.001 77 nm and 1.96degrees respectively. Structure comparison indicates that there is no obvious conformaional change between P450cam and the F87UY96F/L244A/V247A mutant. After mutation, the structure of the active pocket became larger but its hydrophobility increased, which are consistent with the aim of mutantion.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2004年第7期611-615,共5页 Progress In Biochemistry and Biophysics
关键词 P450cam 四突变体 纯化 双波长检测 晶体结构 P450cam four mutants purification double UV check crystal structure
  • 相关文献

参考文献13

  • 1Ortiz de Montellano P R. Cytochrome P450: Structure, Mechanism,and Biochemistry, New York: Plenum Press, 1995. 456 -473
  • 2Nelson S R, Koymans L, Nebert D W, et al. P450 supeffamily:update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 1996, 6 (5): 1 - 42
  • 3Poulos T L. Cytochrome P450. Curr Opin Stmct Biol, 1995, 5( 6 ): 767 - 774
  • 4Hasemann C A, Peterson J A, Deisenhofer J. Crystal structure and refinement of cytochrome P450terp at 2. 3 A resolution. J Mol Biol,1994, 236 (4): 1169 -1185
  • 5Poulos T L, Finzel B C, Gunsalus I C, et al. The 2.6A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem,1985, 260 (30): 16122 -16130
  • 6Cupp-Vickey J E, Poulos T L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nature Struct Biol, 1995, 2:144 - 153
  • 7Nickerson D P, Harford-Cross C F, Wong L L, et al. The catalytic activity of cytochrome P450cam towards styrene oxidation is increased by site-specific mutagenesis. FEBS Lett, 1997, 405(2): 153 - 156
  • 8Bell S G, Chen X, Xu F, et al. Molecular recognition in ( + ) -alpha-pinene oxidation by cytochrome P450cam. Biochem Soc Trans, 2003, 31 ( Pt 3): 558 - 562
  • 9Chen X, Christopher A, Jones J P, et al. Crystal structure of the F87W/Y96F/V247L mutant of cytochrome P-450cam with 1,3,5-trichlorobenzene bound and further protein engineering for the oxidation of pentachlorobenzene and hexachlorobenzene. J Biol Chem, 2
  • 10Bell S G, Chen X, Sowden R J, et al. Molecular recognition in(+) -alpha-pinene oxidation by cytochrome P-450cam. J Am Chem Soc, 2003, 125 (3): 705 -714

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部